Search

Your search keyword '"Douglas, Mark W."' showing total 316 results

Search Constraints

Start Over You searched for: Author "Douglas, Mark W." Remove constraint Author: "Douglas, Mark W."
316 results on '"Douglas, Mark W."'

Search Results

1. Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants

2. Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B

3. BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial

4. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

6. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

7. Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis.

8. Inhibition of Cellular Factor TM6SF2 Suppresses Secretion Pathways of Hepatitis B, Hepatitis C, and Hepatitis D Viruses.

9. Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across Australia

11. Epidemiology of Coronavirus Disease in Gansu Province, China, 2020

12. BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial

15. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

18. FibroGENE: A gene-based model for staging liver fibrosis

19. A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

20. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

21. Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review.

23. Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis B, Hepatitis C and Hepatitis D viruses

26. COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll Out

27. Global multi-stakeholder endorsement of the MAFLD definition

28. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

29. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

30. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

31. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

32. Global multi-stakeholder endorsement of the MAFLD definition

36. SHARED: An International Collaboration to Unravel Hepatitis C Resistance

38. SHARED : An International Collaboration to Unravel Hepatitis C Resistance

39. SHARED: an international collaboration to unravel Hepatitis C resistance

40. Targeting liver metabolism: a pathway to cure hepatitis B virus?

45. The heavy chain of conventional kinesin interacts with the SNARE proteins SNAP25 and SNAP23

Catalog

Books, media, physical & digital resources